In vitro and in vivo pharmacological characterization of the novel NK1 receptor selective antagonist NetupitantAnna Rizzi, Girolamo Calò, Barbara Campi et al.|Peptides|2012Cited by 62
<scp>[Dmt<sup>1</sup>]N/OFQ(1–13)‐NH<sub>2</sub></scp>: a potent nociceptin/orphanin<scp>FQ</scp>and opioid receptor universal agonistStefano Molinari, Remo Guerrini, Severo Salvadori et al.|British Journal of Pharmacology|2012Cited by 41
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQRemo Guerrini, Girolamo Calò, Erika Marzola et al.|Bioorganic & Medicinal Chemistry|2014Cited by 37
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin<scp>FQ</scp>receptor antagonist<scp>NiK</scp>‐21273 in comparison with<scp>SB</scp>‐612111Matteo Marti, Michele Morari, F Mela et al.|British Journal of Pharmacology|2012Cited by 28
Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505)Nikolas Dietis, David G. Lambert, John E. McDonald et al.|British Journal of Anaesthesia|2011Cited by 18